GPUS Q3 2025 Earnings Loss Per Share of 039 Highlights Ongoing PreRevenue Status BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline NEON Q1 2026 Earnings EPS Misses Estimates Amid Elevated Operating Costs INTR Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Movement Neogen Corporation NEOG Q1 2026 Earnings Strong EPS Surprise Drives 53 Beat Above Estimates Dave Busters PLAY Q1 2026 Earnings Massive EPS Miss on Estimated Loss But Stock Rises Amid Strategic Shifts